NYSE$CC
The Chemours · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Chemours' first quarter was marked by growth in TSS and APM segments, with record results in TSS driven by Opteon demand. The company reaffirmed its full-year Adjusted EBITDA and Free Cash Flow guidance.
Chemours reported Net Sales of $1.5 billion, Net Income of $145 million, and Adjusted EBITDA of $304 million for Q1 2023. The company experienced strong performance in its Thermal & Specialized Solutions (TSS) segment, driven by demand for OpteonTM solutions, while the Titanium Technologies (TT) segment faced challenges due to lower demand.
- Net Sales reached $1.5 billion, with Net Income at $145 million and EPS of $0.96.
- Adjusted Net Income was $148 million, with Adjusted EPS at $0.98.
- Adjusted EBITDA stood at $304 million.
- Thermal & Specialized Solutions (TSS) achieved record first-quarter results, driven by strong pricing and demand for OpteonTM solutions.
Headline financials
Revenue & EPS history
Chemours · Revenue · Quarterly
$1.54B
Forward guidance
The Company is reaffirming its full year 2023 Adjusted EBITDA and Free Cash Flow guidance. The Company expects full year 2023 Adjusted EBITDA to be within the range of $1.20 - $1.30 billion and expects Free Cash Flow of greater than $350 million, inclusive of approximately $400 million of capital expenditures.
Tailwinds
- The Company is reaffirming its full year 2023 Adjusted EBITDA guidance.
- The Company is reaffirming its full year 2023 Free Cash Flow guidance.
- The Company expects full year 2023 Adjusted EBITDA to be within the range of $1.20 - $1.30 billion
- The company expects Free Cash Flow of greater than $350 million
- Guidance is inclusive of approximately $400 million of capital expenditures.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2023
+1.4%
Avg return
Earnings day
+2.4%
Avg return
5 days after
+1.2%
Avg return
30 days after
55%
27 / 49 earnings
Positive
+24.2%
Q4 2019
Best reaction
-23.0%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -15.7% | -9.6% | -26.8% | |
| Q4 2025 | -16.5% | -11.7% | -13.3% | |
| Q3 2025 | +6.8% | +7.4% | +8.2% | |
| Q1 2025 | -9.4% | -0.9% | -8.1% | |
| Q4 2024 | +3.9% | -0.4% | -12.8% | |
| Q3 2024 | +11.6% | +11.1% | +19.4% | |
| Q2 2024 | -15.0% | -22.5% | -19.6% | |
| Q1 2024 | -6.1% | -4.0% | -7.6% | |
| Q4 2023 | -4.1% | +5.0% | -0.2% | |
| Q3 2023 | -0.1% | +2.1% | +11.7% | |
| Q2 2023 | -4.8% | -4.0% | -14.8% | |
| Q1 2023 | +6.4% | +11.1% | +4.4% | |
| Q4 2022 | -1.7% | -0.8% | -10.7% | |
| Q3 2022 | +1.0% | -0.9% | +13.5% | |
| Q2 2022 | +4.0% | +1.6% | +4.5% | |
| Q1 2022 | +17.7% | +21.1% | +31.7% | |
| Q4 2021 | -16.8% | -13.9% | -26.9% | |
| Q3 2021 | +8.0% | +4.7% | -3.0% | |
| Q2 2021 | +1.9% | +4.7% | +6.5% | |
| Q1 2021 | +4.4% | +14.7% | +23.0% | |
| Q4 2020 | -2.6% | -1.8% | +7.1% | |
| Q3 2020 | +2.2% | +8.3% | +23.0% | |
| Q2 2020 | -0.3% | +5.9% | +12.8% | |
| Q1 2020 | +12.9% | +18.3% | +44.4% | |
| Q4 2019 | +24.2% | +19.1% | -33.9% | |
| Q3 2019 | +13.9% | +13.4% | -11.1% | |
| Q2 2019 | -23.0% | -26.5% | -25.7% | |
| Q1 2019 | -1.8% | -16.4% | -39.4% | |
| Q4 2018 | -2.6% | -3.0% | -2.2% | |
| Q3 2018 | +4.1% | +2.9% | -13.7% | |
| Q2 2018 | +4.9% | +6.7% | -2.8% | |
| Q1 2018 | +4.5% | +4.4% | +1.7% | |
| Q4 2017 | +2.7% | +2.5% | +4.5% | |
| Q3 2017 | -8.4% | -10.5% | -9.0% | |
| Q2 2017 | -1.6% | +3.8% | +4.3% | |
| Q1 2017 | -1.0% | +2.4% | -0.7% | |
| Q4 2016 | -0.5% | +3.1% | +8.4% | |
| Q3 2016 | +12.7% | +21.1% | +52.3% | |
| Q2 2016 | +13.2% | +25.8% | +49.6% | |
| Q1 2015 | -3.1% | — | — | |
| Q1 2016 | +9.6% | — | — | |
| Q1 2014 | +2.3% | — | — | |
| Q4 2013 | +2.3% | — | — | |
| Q4 2015 | +14.3% | — | — | |
| Q3 2014 | -17.2% | — | — | |
| Q3 2015 | -17.2% | — | — | |
| Q4 2014 | +16.3% | — | — | |
| Q2 2014 | +16.3% | — | — | |
| Q2 2015 | +16.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro